The preclinical development of roferon®‐A

Cancer

Volumn 57, Issue 8 S, 1986, Pages 1648-1656

  Trown, Patrick W ^a   Wills, Robert J ^a   Kamm, Jerome J ^a  

^a HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2A INTERFERON; ANTIVIRUS AGENT; IMMUNOMODULATING AGENT; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT DNA; RECOMBINANT INTERFERON;

BACTERIUM; BLOOD AND HEMOPOIETIC SYSTEM; CANCER CHEMOTHERAPY; COLONY FORMATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG TOXICITY; HUMAN; IMMUNOMODULATION; INTOXICATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; IRRITATION; LEUKOCYTE; MONKEY; MOUSE; MUSCLE; NONHUMAN; PERIPHERAL VASCULAR SYSTEM; PHARMACOKINETICS; PHLEBITIS; PRIORITY JOURNAL; RAT; REVIEW; SPECIES DIFFERENCE; THERAPY; TUMOR CELL; VIRUS INFECTION;

ANIMAL; ANTIBODY FORMATION; CATTLE; CELL LINE; CELLS, CULTURED; DRUG EVALUATION, PRECLINICAL; HAMSTERS; HAPLORHINI; HUMAN; INTERFERON TYPE I; METABOLIC CLEARANCE RATE; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; RABBITS; RATS; RECOMBINANT PROTEINS; SPECIES SPECIFICITY; TUMOR STEM CELLS; VIRUS DISEASES;

EID: 0022632301     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19860415)57:8+<1648::AID-CNCR2820571303>3.0.CO;2-O     Document Type: Article

References (44)

1. Why is interferon not in clinical use today?
2. Human leukocyte interferon produced by E. coli is biologically active
3. Species specificity of interferons
4. Activity of human recombinant and lymphoblastoid interferons in human and heterologous cell lines
5. Virus interference: I. The interferon
6. Cell and virus sensitivity studies with recombinant human alpha interferons
7. Comparison of the antiviral activities of various cloned human interferon‐α subtypes in mammalian cell cultures
8. Antiviral effects of bacteria‐derived human leukocyte interferon against encephalomyocarditis virus infection of squirrel monkeys
9. In vivo antiviral activity of recombinant type α interferon A in monkeys with infections due to simian varicella virus
10. Effective treatment of a genital herpes simplex virus type 2 infection of guinea pigs with recombinant human leukocyte A interferon
11. Synergistic antiviral and antiproliferative activities of Escherichia coli‐derived human alpha, beta and gamma interferons
12. Enhancement of the antiproliferative activity of human interferon by polyamine depletion
13. Low interferon binding activity of two human cell lines which respond poorly to the antiviral and antiproliferative activity of interferon
14. Stimulation of natural killer cell activity and inhibition of proliferation of various leukemic cells by purified human leukocyte interferon subtypes
15. Recombinant human leukocyte interferon produced in bacteria has antiproliferative activity
16. Human leukocyte interferon subtypes have different antiproliferative and antiviral activities on human cells
17. Differential effect of recombinant human leukocyte interferon on human leukemic and normal myeloid progenitor cells
18. Effects of fibroblast and recombinant leukocyte interferons and double‐stranded RNA on ppp(2'‐5')An synthesis and cell proliferation in human colon carcinoma cells. in vitro
19. Effects of cloned human leukocyte interferons in the human tumor stem cell assay
20. Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma
21. Treatment of advanced renal cell cancer with recombinant leukocyte A interferon (Abstr)
22. Investigational therapy of renal cell carcinoma with recombinant alpha interferon (Abstr)
23. Phase II study of recombinant leukocyte A interferon (rIFN‐αA) in disseminated malignant melanoma
24. Treatment of hairy cell leukemia with recombinant DNA‐derived interferon alfa‐2a (Abstr)
25. The action of six different human interferons on human tumors grown as xenografts in nude mice
26. On the mechanism of the antitumor effect of interferon in mice
27. Antitumor effects of interferon in mice injected with interferon‐resistant and interferon‐sensitive leukemia cells: I
28. Antiviral activities of hybrids of two major human leukocyte interferons
29. Specific molecular activities of recombinant and hybrid leukocyte interferons
30. Importance of treatment regimen of interferon as an antitumor agent
31. Treatment regimen and host T‐cell‐dependent therapeutic effect of interferon in mouse solid tumors
32. Convenient assay for interferons
33. Interferon: Greatly simplified enzyme immunoassay with two monoclonal antibodies
34. Pharmacokinetics of recombinant alpha A interferon following i.v. infusion and bolus i.m. and p.o. administration to African green monkeys
35. Interferon kinetics and adverse reactions after intravenous, intramuscular, and subcutaneous injection
36. Use of the isolated perfused kidney as a tool in drug disposition studies
37. Renal filtration, absorption and catabolism of human alpha interferon
38. The kidney is the main site of interferon catabolism
39. Involvement of the kidney in catabolism of human leukocyte interferon
40. The kidney is the main site of interferon degradation
41. 125I‐interferon alpha by isolated perfused rabbit kidney and liver
42. Pharmacokinetics of recombinant leukocyte A interferon following various routes and modes of administration to the dog